Physician profile
Stephen E Parey
NPI 1093753626
$4,072.71
in general payments reported to CMS, 2019-2025
34 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $128 · 2021: $681 · 2022: $326 · 2023: $670 · 2024: $1,123 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724 · Consulting Fee: $685 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.93 |
| Consulting Fee | $685.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $550.00 | 2024 | Bronchoscope |
| Inspire Medical Systems, INC. | $508.93 | 2019-2025 | Inspire |
| Glaxosmithkline, LLC. | $423.88 | 2019-2025 | Nucala |
| Aerin Medical INC. | $382.11 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $317.65 | 2019-2024 | Dupixent |
| Stryker Corporation | $247.38 | 2019-2025 | Scopis Ent, Shaver System |
| Jazz Pharmaceuticals INC. | $236.94 | 2019-2025 | |
| Medtronic, INC. | $170.58 | 2021-2024 | Straightshot, Skeeter, Merocel |
| Genzyme Corporation | $154.29 | 2019-2025 | |
| Microline Surgical INC | $125.81 | 2021 | |
| Intersect Ent, INC. | $95.86 | 2019-2021 | |
| 3b Medical, INC. | $79.38 | 2023-2025 | Luna |
| Astrazeneca Pharmaceuticals Lp | $75.82 | 2023-2025 | Airsupra, Tezspire |
| Acclarent, INC | $68.91 | 2023-2024 | Trudi Nav Cable |
| Alk-Abello, INC | $55.70 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $49.09 | 2025 | Neffy |
| Smith+Nephew, INC. | $47.00 | 2024-2025 | Tula |
| Harmony Biosciences LLC | $43.59 | 2021-2022 | |
| Pfizer INC. | $42.78 | 2023-2025 | |
| Abbvie INC. | $40.79 | 2024 | |
| Merck Sharp & Dohme LLC | $39.14 | 2021-2023 | |
| Phadia US INC. | $37.87 | 2019-2024 | Immunocap |
| Amgen INC. | $34.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.98 | 2019-2025 | |
| Philips North America LLC | $30.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.39 | 2025 | Elaprase |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.18 | 2022 | |
| Phathom Pharmaceuticals, INC. | $25.00 | 2025 | Voquezna |
| Hologic Sales and Service, LLC | $22.03 | 2023 | Coolseal Generator |
| Optinose US, INC. | $21.60 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.56 | 2022 | |
| Seqirus USA INC | $16.45 | 2024 | Flucelvax, Fluad |
| Hikma Pharmaceuticals USA | $16.31 | 2023 | Ryaltris |
| Lundbeck LLC | $15.53 | 2023 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Parey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.